Kirk Nahra, Robyn Eckerling
This session will address new risks and opportunities for companies operating in the digital health space, including implications of website tracking, effects from the Good RX decision, navigating HIPAA and non-HIPAA risks and how best to prepare for an investigation.
Kirk Nahra, Partner, WilmerHale
Robyn Eckerling, CPO, Tempus Labs
Readings:
